Share
PDF
Other content recommended for you
- Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
- Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study
- Monitoring, reporting and regulating medicine quality: tensions between theory and practice in Tanzania
- Spurious and counterfeit drugs: a growing industry in the developing world
- Evaluation of the decision-making process underlying the initial off-label use of vaccines: a scoping review protocol
- Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers
- Unlicensed and off label drug use in paediatric wards: prospective study
- Unlicensed and off label drug use in neonates
- Off-label use of bevacizumab in the treatment of retinal disease: ethical implications
- Unlicensed and off label prescribing of drugs in general practice